Jeffrey Hung Stock Analyst Profile - Morgan Stanley Research Coverage - Stocknear

Jeffrey Hung

Stock Analyst at Morgan Stanley

(3.97)
# 2039
Out of 5,504 analysts
281
Total ratings
Success rate
Average return

42 Stocks

Name Action PT Current % Upside Ratings Updated
CRNX Crinetics Pharmaceut...
Maintains: Overweight
65 77
40.62 89.56% 3 Sep 29, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Overweight
109 122
102.08 19.51% 13 Sep 25, 2025
JAZZ Jazz Pharmaceuticals
Maintains: Overweight
163 167
139.72 19.52% 10 Sep 24, 2025
CGON CG Oncology
Maintains: Overweight
56 79
39.67 99.14% 5 Sep 17, 2025
ENGN enGene Holdings
Maintains: Overweight
19 18
7.91 127.56% 4 Sep 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
158 163
136.1 19.76% 27 Sep 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
76 71
66.91 6.11% 13 Aug 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
35 28
6 366.67% 7 Aug 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
20 21
11.01 90.74% 4 Aug 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
4 2
2.42 -17.36% 4 Aug 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 13
8.37 55.32% 6 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
102 108
8.39 1187.25% 5 Jul 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
65 55
31.02 77.3% 9 Jul 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
20 24
21.66 10.8% 25 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
85
66.82 27.21% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 27
23.28 15.98% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Underweight
5
5.74 -12.89% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
70 67
57.2 17.13% 13 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 95
n/a n/a 5 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
35
8.58 307.93% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
295 330
n/a n/a 3 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 4
1.49 168.46% 10 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
13 4
n/a n/a 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1 4
1.18 238.98% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
60 140
n/a n/a 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 14
6.46 116.72% 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
5 5
4.08 22.55% 1 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
9 3
3.02 -0.66% 8 Mar 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 14
1.83 665.03% 7 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 21
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
4 2
n/a n/a 3 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 10
2.13 369.48% 3 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
22 30
n/a n/a 6 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 22
40.96 -46.29% 10 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
2 2
n/a n/a 5 Sep 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
250 94
n/a n/a 8 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
146 149
15.84 837.5% 2 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
180
n/a n/a 12 Oct 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
100 60
1.53 3821.57% 5 Aug 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 6
4.8 25% 9 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
121 225
n/a n/a 9 Oct 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
696 648
5.84 10995.89% 6 May 8, 2020